CD8A and neoplasm: Regarding prognosis, reduced peritumoral CD8+T-cell counts were associated with worse survival time of the patients in the univariate (p = 0.0372) but not in the multivariate analysis when adjusted for T-, N-, M-stage, tumor budding and therapy (p = 0.8862, Suppl.